TVM Capital MENA receives DFSA approval to start regional healthcare growth capital fund

NewsGuard 100/100 Score

TVM Capital MENA today announced that it has received the approval of the Dubai Financial Services Authority (DFSA) to start operation of its first regional healthcare growth capital fund with US$40 million of subscriptions from founding investors, Saudi Health Investment Company (SHIC), the International Finance Corporation (IFC), and GE Healthcare. TVM Capital MENA Ltd., the fund’s operator, is based in the Dubai International Financial Centre (DIFC) and is licensed and regulated by the DFSA.

“German Private Equity Firm of the Year 2008”

The fund established by TVM Capital MENA is the first healthcare-dedicated fund in the MENA region to be operated by a leading global healthcare and life science manager with a significant track record in the sector. The Fund will seek to capitalise on the substantial growth opportunities in the healthcare service and pharmaceutical/life science sectors in the Middle East and North Africa (MENA) region. On the services side, the focus will be on investments in specialised clinics, medical laboratories, small hospitals, diagnostic imaging centres, providers of outsourced services to healthcare delivery facilities, clinical trial management services, and healthcare IT and insurance. On the life science product side, investments will focus on pharmaceutical and other life science product companies that are involved in the licensing, import, manufacture and distribution of medicines, medical devices and diagnostics.

Abdulla Mohammed Al Awar, CEO of the DIFC Authority said: “While the current economic environment has posed many challenges, it has also presented several new opportunities for private equity funds. The global financial crisis has shown the need for private equity firms to focus on the fundamental profitability and growth of the companies they invest in. In this light, some of the most exciting opportunities for private equity in the MENA region lie in the healthcare sector. By providing a world-class legal and regulatory framework, DIFC offers a secure and productive platform for private equity firms like TVM Capital MENA to operate their funds and develop their business.”

Kevin Birkett, Executive Director - Asset Management, DIFC Authority said: “DIFC’s commitment to maintain the highest global standards of transparency and integrity has made it a natural base for financial services firms. Funds management is one of the strategic sectors that DIFC is focusing its development efforts on. Over the last few years, DIFC has introduced supportive legislation specifically aimed at tapping the growth potential of this sector in the MENA region. Healthcare represents one of the most promising growth areas for private equity funds in the region and we are keen to provide all the support we can to facilitate the growth of such funds TVM Capital MENA’s healthcare fund.”

Dr. Helmut Schühsler, Chairman of the Board of TVM Capital MENA Ltd. and a Managing Partner of TVM Capital GmbH, Munich said: “The Fund will draw from TVM Capital’s 25 plus years of experience and success in investing in the health market, the firm’s global network in industry and academia as well as the relationships we have built regionally to add significant value to healthcare investment opportunities.”

“Our TVM Capital MENA team will have a strong collaborative relationship with our founding investors. GE Healthcare will add considerable value as a strategic partner to TVM Capital MENA with its expertise in assessing investment opportunities and executing projects in the region. Our relationship with SHIC will translate into an increased presence in the Kingdom of Saudi Arabia and other countries, especially in the GCC and Egypt, where SHIC is a leading investor in healthcare services. The IFC has a strong presence in several countries in the region and a large team dedicated to healthcare investments,” He added

A team of professionals led by Managing Director, Marios Fotiadis, will manage operational investment activities, including all deal sourcing, origination, assessments, and deal execution. Fotiadis was a General Partner of TVM Capital in Munich and Boston for two years before taking charge of the MENA investment operations. He has a 14-year background in the industry as an M&A banker and multi-national healthcare investor with Cowen Capital Partners and Advent International. The investment team also includes Youssef Haidar, formerly a Managing Director at Unifund Capital, Abu Dhabi, and strategic partner, Munich Medical International (MMI), represented by Managing Partner, Prof. Dr. Frank Christ. MMI is a Munich and Dubai-based healthcare services advisory firm with substantial operating experience in the region.

Marios Fotiadis said: “We believe there is a substantial investment opportunity in the MENA region, which is experiencing high population and GDP growth, while being chronically undersupplied, both qualitatively and quantitatively, in the healthcare sector. We have fully validated our investment thesis through our ability to develop a robust and proprietary deal flow, and we will shortly be announcing the close of our first two investments.”

To establish operations in Dubai, TVM Capital MENA entered into a joint venture with Boston BioCapital FZ LLC, a Dubai-based advisory firm led by Hoda Abou-Jamra, a founding partner of the Fund. The partnership between the two firms covered the coordination of all start-up activities, access to potential investors, investment opportunities, professionals and advisors in the region as well as general marketing and relationship building.

Source  TVM Capital MENA Ltd.,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Top minds in multiple sclerosis to speak at CMSC 38th Annual Meeting